Tuesday, August 19, 2025
HomePharma

Pharma

Pharma

Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce First Paragraph IV Filing and Acceptance by FDA

Life Sciences Times - 0
Pharma

Gilead Presents Real-World Evidence Reinforcing the Use of Biktarvy® for the Treatment of People Living With HIV With a Range of Comorbidities

Life Sciences Times - 0
Pharma

Novaliq Announces FDA Acceptance of the New Drug Application for CyclASol® for the Treatment of Dry Eye Disease

Life Sciences Times - 0
Pharma

Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® Tablets for the Treatment of Chorea Associated with Huntington’s Disease

Life Sciences Times - 0
Pharma

Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for Cholestatic Pruritus

Life Sciences Times - 0
Pharma

CHMP recommends conditional marketing authorization for Spesolimab as first in class treatment option for generalized pustular psoriasis flares

Life Sciences Times - 0
Pharma

CANbridge-UMass Chan Medical School Gene Therapy Research in Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 29th Annual Congress

Life Sciences Times - 0
Pharma

4Moving Biotech Announces First Patient Enrolled in Phase I Clinical Trial on Osteoarthritis

Life Sciences Times - 0
Pharma

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age

Life Sciences Times - 0
Pharma

U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Gilead’s Trodelvy® for Pre-Treated HR+/HER2- Metastatic Breast Cancer

Life Sciences Times - 0
Pharma

ADOCIA Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes using M1Pram in a post-hoc analysis

Life Sciences Times - 0
Pharma

Revelation Biosciences Inc. and Vanderbilt University Enter Exclusive Worldwide License Agreement

Life Sciences Times - 0
1...323334...77Page 33 of 77

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv